Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_assertion type Assertion NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_head.
- NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_assertion description "[TET2 mutations improve the ELN molecular-risk classification in primary CN-AML because of their adverse prognostic impact in an otherwise favorable-risk patient subset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_provenance.
- NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_assertion evidence source_evidence_literature NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_provenance.
- NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_assertion SIO_000772 21343549 NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_provenance.
- NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_assertion wasDerivedFrom befree-20140225 NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_provenance.
- NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_assertion wasGeneratedBy ECO_0000203 NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_provenance.